We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


BIOKE and Fluidigm Announce Exclusive Distribution Agreement

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Fluidigm Corporation and BIOKE have announced an agreement in which BIOKE is appointed as exclusive distributor for the BioMark™ System for real-time PCR and genotyping in the Benelux.

The Fluidigm says that the BioMark system provides orders-of-magnitude increase in throughput compared to conventional RT-PCR and genotyping platforms, at a fraction of the labor and running cost. This breakthrough is possible because the BioMark system reads dynamic arrays – nanofluidic chips that contain preprogrammed fluidic networks that automatically combine sets of samples with sets of PCR assays.

BioMark dynamic arrays can provide a high-throughput and means to validate gene- or SNP-based biomarkers by PCR. An array generates 2,304 PCR assays, yet it requires only 96 pipetting steps (input of 48 off-the-shelf primer-probe sets and 48 samples), or 1/40 the pipetting steps required by 384-well systems.